Privately owned drug discovery company Nimbus Therapeutics on Tuesday announced that it expanded its research collaboration with Eli Lilly (LLY) to develop an oral obesity therapy in a deal worth up ...
Eli Lilly has returned to Nimbus Therapeutics for another metabolic collaboration, this time focused on the red-hot R&D space of oral obesity therapies. The latest partnership will see Lilly pass ...
Marvel actress Evangeline Lilly has announced that she's suffered brain damage due to an accident last year, and is now "functioning at a decreased capacity." The star, best known for her Marvel role ...
Evangeline Lilly is sharing an update on her health following an unfortunate accident in May 2025. In an Instagram video posted on Friday, Jan. 2, the 46-year-old "Lost" star shared that she has ...
Southern Hospitality‘s Grace Lilly has been arrested for harassment — with police allegedly finding “happy pills” in her purse. Us Weekly can confirm that Lilly, 27, was booked in Charleston, South ...
Orforglipron maintains weight loss after switching from injectable GLP-1 drugs Lilly and Novo Nordisk await U.S. regulatory approvals for weight-loss pills FDA may expedite review of Lilly's ...
Eli Lilly's next-gen anti-obesity candidate hit it out of the park in a phase 3 study. This should help solidify the company's lead in this niche of the industry. Even after their strong run, Lilly's ...
Marc Santos is a Guides Staff Writer from the Philippines with a BA in Communication Arts and over six years of experience in writing gaming news and guides. He plays just about everything, from ...
Eli Lilly’s weight loss drugs have delivered blockbuster sales in recent quarters. The company is a leader in this market today and has a pipeline of promising candidates to potentially reinforce its ...
The Lord of Hatred expansion, which focuses on the fight against Mephisto, will also include a second new class and several changes to endgame content. Adam Benjamin has helped people navigate complex ...
Eli Lilly has surpassed analysts’ highest hopes for the efficacy of retatrutide, linking the triple agonist to 28.7% weight loss and a 75.8% reduction in pain scores in patients with obesity and knee ...
Blizzard has confirmed when Diablo 4 Season 11 will begin, and it's coming a couple of days later than we initially expected, and one of the most anticipated features in the update isn't arriving ...